MULTICYCLIC COMPOUNDS FOR USE AS MELANIN CONCENTRATING HORMONE ANTAGONISTS IN THE TREATMENT OF OBESITY AND DIABETES

The present invention relates to a melanin concentrating hormone antagonist compound of formula I: (I); or a pharmaceutically acceptable salt, solvate, enantiomer or prodrug thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MICHAEL, ALAN ROBERTSON, JAMES, RONALD GILLIG, PHILIP, ARTHUR HIPSKIND, CARSTEN OTT, LAWRENCE, JOHN SLIEKER, MICHAEL, DEAN KINNICK, YEN-SHI LAI, KENNETH, ALLEN SAVIN, LAWRENCE, JOSEPH HEINZ, JAMES, ARTHUR NIXON, JOCHEN AMMENN, JOHN, MICHAEL, JR. MORIN, NANCY, JUNE SNYDER, THEO SCHOTTEN
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a melanin concentrating hormone antagonist compound of formula I: (I); or a pharmaceutically acceptable salt, solvate, enantiomer or prodrug thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.